Conjunctival squamous cell carcinoma

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Conjunctival squamous cell carcinoma
Conjunctival squamous cell carcinoma
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Red eye, eye irritation, vision loss
Complications Metastasis, vision impairment
Onset Typically in adulthood
Duration Chronic
Types N/A
Causes Human papillomavirus, ultraviolet light exposure
Risks Immunosuppression, HIV/AIDS, xeroderma pigmentosum
Diagnosis Biopsy, slit lamp examination
Differential diagnosis Pinguecula, pterygium, conjunctivitis
Prevention N/A
Treatment Surgical excision, cryotherapy, topical chemotherapy
Medication Mitomycin C, 5-fluorouracil
Prognosis Generally good with treatment
Frequency Rare
Deaths N/A


Conjunctival Squamous Cell Carcinoma (CSCC) is a type of cancer that occurs on the conjunctiva, which is the thin, transparent membrane covering the white part of the eye and the inner surfaces of the eyelids. CSCC is a form of squamous cell carcinoma, which is characterized by the abnormal growth of squamous cells. While it is a rare condition, it is considered the most common malignancy of the ocular surface.

Causes and Risk Factors[edit]

The exact cause of CSCC is not fully understood, but several risk factors have been identified. Prolonged exposure to ultraviolet (UV) radiation is considered a significant risk factor, as it can cause damage to the DNA of conjunctival cells. Other risk factors include exposure to certain chemicals (such as arsenic), Human Papillomavirus (HPV) infection, and immunosuppressive conditions.

Symptoms[edit]

Symptoms of CSCC may include a noticeable growth on the conjunctiva, redness or irritation of the eye, a sensation of a foreign body in the eye, and in some cases, vision impairment. The appearance of the tumor can vary, but it often presents as a pink, fleshy mass. It is important to note that early stages of CSCC may be asymptomatic.

Diagnosis[edit]

Diagnosis of CSCC involves a thorough examination of the eye by an ophthalmologist. This may include slit-lamp examination, biopsy of the lesion, and imaging tests such as ultrasound or MRI to determine the extent of the tumor. Histopathological examination of the biopsy sample is crucial for confirming the diagnosis.

Treatment[edit]

Treatment options for CSCC depend on the size, location, and extent of the tumor, as well as the overall health of the patient. Small, localized tumors may be treated with surgical excision, while larger or more aggressive tumors may require additional therapies such as cryotherapy, radiotherapy, or chemotherapy. In some cases, a combination of treatments may be necessary. Early detection and treatment are key to preventing the spread of the cancer and preserving vision.

Prognosis[edit]

The prognosis for patients with CSCC is generally good, especially when the cancer is detected and treated early. However, the risk of recurrence is significant, and regular follow-up with an ophthalmologist is important for early detection of any recurrence or new tumors.

Prevention[edit]

Preventive measures against CSCC include protecting the eyes from excessive UV exposure by wearing UV-protective sunglasses and hats when outdoors. Regular eye examinations are also important, particularly for individuals at higher risk due to known risk factors.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.